Asthma
Not recruitingStudy on the Effectiveness and Safety of Benralizumab for Children with Severe Eosinophilic Asthma
- Disease:Asthma
- Substances:Benralizumab
Italy- Participants:0–17 years
- Substances:Benralizumab
- Sponsor:AstraZeneca AB
Rare diseases
Investigational molecules
Locations
Back to Italy1 clinical trial in Ponte San Pietro, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on severe eosinophilic asthma in pediatric patients, investigating innovative treatments to reduce asthma exacerbations and improve lung function.
Research evaluating the effectiveness of benralizumab in managing severe asthma cases characterized by elevated eosinophil levels in young patients.
Studies examining new treatment approaches for uncontrolled asthma in children and adolescents, with a focus on reducing inflammatory responses.
Innovative research aimed at understanding the role of white blood cells in pediatric airway inflammation and disease progression.
Investigation into the relationship between eosinophil levels and asthma severity, exploring targeted therapeutic interventions for young patients.
Research focusing on understanding and treating severe asthma through immunological approaches in pediatric populations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.